NASDAQ · Biotechnology

CDT Equity Inc. (CDT) Stock

$0.72 -10.25% NASDAQ: CDT Healthcare

Valuation

MetricValue
Price$0.72
Market Cap$553383
P/E Ratio0.01
P/B Ratio0.02
P/S Ratio0.01
EPS (TTM)$0.00
52-Week High$44450.00
52-Week Low$0.71
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE9.26%
ROA2.60%
ROCE5.86%
Gross Margin11.60%
Operating Margin11.64%
Net Margin6.30%
Debt/Equity0.95
Current Ratio1.94

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-3.0M$-5.0M$-15.0M$-37.0M
Net Profit$-4.0M$-5.0M$-1.0M$-18.0M$-39.0M
EPS$-750.00$-201360.00$-267600.00$-615930.00$-11778.00
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$7.0M$4.0M$3.5B
Total Liabilities$0$10.0M$8.0M$11.0M$2.3B
Cash$0$0$4.0M$1.0M$390.0M
Borrowings$0$2.0M$1.0M$7.0M$1.3B

Latest News

CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane GlobeNewswire · Jul 20, 2026 CDT Equity Implements 1-for-10 Reverse Stock Split MT Newswires · Jul 16, 2026 CDT Equity Inc. Announces Reverse Stock Split GlobeNewswire · Jul 16, 2026 CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development GlobeNewswire · Jun 26, 2026 BC-Most Active Stocks Associated Press · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-2.0M$-8.0M$-10.0M$-16.0M
Investing Cash Flow$0$0$1.0M$0$-3.0M
Financing Cash Flow$0$0$8.0M$0$0
Net Cash Flow$0$0$4.0M$-4.0M$1.0M
Free Cash Flow$-2.0M$-2.0M$-8.0M$-10.0M$-18.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA3.99
FCF Yield-182.95%
Quick Ratio1.49
Interest Coverage-6.20
Return 1Y-99.92%
Return 3Y-100.00%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CCMConcord Medical Services Holdings Limited $4.32 +7.20% -0.03 $629052 0.00%
COCHEnvoy Medical, Inc. $0.66 +0.03% -0.97 $50.78M 0.00%
ENVBEnveric Biosciences, Inc. $1.45 -4.61% -0.09 $6.49M 0.00%
HEPAHepion Pharmaceuticals, Inc. $0.05 +17.78% -0.21 $617116 0.00%
LIXT $7.21 -6.00% -5.30 $89.11M 0.00%

About CDT Equity Inc.

CDT Equity Inc. is led by CEO Andrew Regan, employs 6 people, headquartered in US, publicly traded since 2022.

CDT Equity Inc. (CDT) stock trades at $0.72 with a market capitalization of $553383. The stock is valued at a price-to-earnings (P/E) ratio of 0.01, price-to-book of 0.02, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.71 and $44450.00, and currently trades 100.0% below its 52-week high.

On profitability, CDT Equity Inc. generates a return on equity (ROE) of 9.26%, return on capital employed of 5.86%, an operating margin of 11.64%, a net profit margin of 6.30%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides